Mark J. Smyth
Mark J. Smyth
Verified email at
TitleCited byYear
Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion
RD Schreiber, LJ Old, MJ Smyth
Science 331 (6024), 1565-1570, 2011
Natural innate and adaptive immunity to cancer
MD Vesely, MH Kershaw, RD Schreiber, MJ Smyth
Annual review of immunology 29, 235-271, 2011
Adaptive immunity maintains occult cancer in an equilibrium state
CM Koebel, W Vermi, JB Swann, N Zerafa, SJ Rodig, LJ Old, MJ Smyth, ...
Nature 450 (7171), 903, 2007
Immune surveillance of tumors
JB Swann, MJ Smyth
The Journal of clinical investigation 117 (5), 1137-1146, 2007
NKT cells: what's in a name?
DI Godfrey, HR MacDonald, M Kronenberg, MJ Smyth, L Van Kaer
Nature Reviews Immunology 4 (3), 231, 2004
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors
F Ghiringhelli, L Apetoh, A Tesniere, L Aymeric, Y Ma, C Ortiz, ...
Nature medicine 15 (10), 1170, 2009
Functional significance of the perforin/granzyme cell death pathway
JA Trapani, MJ Smyth
Nature Reviews Immunology 2 (10), 735, 2002
NKT cells: facts, functions and fallacies
DI Godfrey, KJL Hammond, LD Poulton, MJ Smyth, AG Baxter
Immunology today 21 (11), 573-583, 2000
Differential tumor surveillance by natural killer (NK) and NKT cells
MJ Smyth, KYT Thia, SEA Street, E Cretney, JA Trapani, M Taniguchi, ...
Journal of Experimental Medicine 191 (4), 661-668, 2000
A fresh look at tumor immunosurveillance and immunotherapy
MJ Smyth, DI Godfrey, JA Trapani
Nature immunology 2 (4), 293, 2001
New insights into cancer immunoediting and its three component phases—elimination, equilibrium and escape
D Mittal, MM Gubin, RD Schreiber, MJ Smyth
Current opinion in immunology 27, 16-25, 2014
Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity
MJ Smyth, GP Dunn, RD Schreiber
Advances in immunology 90, 1-50, 2006
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
H Matsushita, MD Vesely, DC Koboldt, CG Rickert, R Uppaluri, VJ Magrini, ...
Nature 482 (7385), 400, 2012
The TRAIL apoptotic pathway in cancer onset, progression and therapy
RW Johnstone, AJ Frew, MJ Smyth
Nature Reviews Cancer 8 (10), 782, 2008
New aspects of natural-killer-cell surveillance and therapy of cancer
MJ Smyth, Y Hayakawa, K Takeda, H Yagita
Nature Reviews Cancer 2 (11), 850, 2002
Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells
K Takeda, Y Hayakawa, MJ Smyth, N Kayagaki, N Yamaguchi, S Kakuta, ...
Nature medicine 7 (1), 94, 2001
Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice
E Cretney, K Takeda, H Yagita, M Glaccum, JJ Peschon, MJ Smyth
The Journal of Immunology 168 (3), 1356-1361, 2002
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
S Loi, S Michiels, R Salgado, N Sirtaine, V Jose, D Fumagalli, ...
Annals of oncology 25 (8), 1544-1550, 2014
Perforin and interferon-γ activities independently control tumor initiation, growth, and metastasis
SEA Street, E Cretney, MJ Smyth
Blood 97 (1), 192-197, 2001
IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses
MA Linterman, L Beaton, D Yu, RR Ramiscal, M Srivastava, JJ Hogan, ...
Journal of Experimental Medicine 207 (2), 353-363, 2010
The system can't perform the operation now. Try again later.
Articles 1–20